RDNT

RadNet, Inc.

Nasdaq · Services-Medical Laboratories · Inc. DE · CIK 0000790526
$54.21 +1.61% $4.2B
High Impact Filing (7/10)5 New Institutional Positions
Vol
Market Cap$4.2B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (93%)
Inst. Holders8 funds
Inst. Value$748.9M
Inst. Activity5 buys / 0 sells
Insider Activity0B / 2S
Insider Net $-$1.5M
Reddit Sentiment50° Neutral
SEC Reports4
Press Releases5
Exchange Nasdaq·Sector Services-Medical Laboratories·Inc. DE·CIK 0000790526·Prev Close $53.35

Recent Activity

May 11, 2026 SEC
RadNet reported record Q1 2026 revenue of $575.6M (+22.1% YoY) and raised full-year Imaging Center guidance for revenue,
8-K — Impact 6/10
May 11, 2026 earnings_calendar
RDNT Q1 2026 Earnings Scheduled — 2026-05-11
May 10, 2026 SEC
RadNet reported Q1 2026 revenue of $575.6M (+22.1% YoY) and Adjusted EBITDA of $63.3M (+36.3% YoY), beating consensus EP
PRESS-RELEASE — Impact 7/10
May 5, 2026 Insider
Berger Howard G sold 25,992 shares
President, CEO @ $18.64 ($484.5K)
May 5, 2026 Insider
Berger Howard G sold 25,992 shares
President, CEO @ $0.00 ($0.00)
Apr 28, 2026 SEC
RadNet reported Q4 2025 EPS of $0.24, a 244.6% beat vs the $0.17 consensus, on revenue of $556.3M (in line with estimate
PRESS-RELEASE — Impact 7/10
Mar 19, 2026 Insider
Sorensen Alma Gregory sold 9,554 shares
Chief Strategy Officer @ $61.84 ($590.8K)
Inst.
MORGAN STANLEY — ADD
949,971 shares ($67.8M)

Price Targets

$90.38 +66.7% upside Strong Buy
Current $54.21 Low $70.00 Median $93.50 High $100.00 8 analysts
$70.00 $100.00

Analyst Ratings

Strong Buy93% buy · 14 analysts
5Strong Buy
8Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 20, 2026 Barclays MAINTAIN Overweight → Overweight
Apr 21, 2026 Barclays MAINTAIN Overweight → Overweight
Jan 9, 2026 Keybanc INITIATE Overweight
Dec 1, 2025 B. Riley Securities MAINTAIN Buy → Buy

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $0.21 ▼ -4.2% $0.17 — $0.28 -31% YoY 5
Next Q $0.27 ▲ +8.7% $0.23 — $0.31 35% YoY 5
Current FY $0.56 ▼ -11.4% $0.45 — $0.73 42% YoY 6
Next FY $1.05 ▲ +1.9% $0.89 — $1.22 88% YoY 5

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$532.5M
MORGAN STANLEY$67.8MADD
CHARLES SCHWAB INVESTMENT MANAGEMENT$54.1MNEW
BANK OF AMERICA CORP$36.6MADD
NORGES BANK$32.2MNEW

Recent Insider Trades

DateInsiderTypeValue
May 5, 2026Berger HowardM$484.5K
May 5, 2026Berger HowardM$0.00
Mar 19, 2026Sorensen AlmaSELL$590.8K
Mar 19, 2026Sorensen AlmaG$0.00
Mar 18, 2026Sorensen AlmaSELL$882.1K

Reddit Sentiment

50°
Neutral
Bearish Neutral Bullish
2 mentions 0 bullish 0 bearish
8 institutional holders with $748.9M total value (10,496,782 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, CHARLES. Net buying activity: 5 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC7,463,101$532.5M71.1%
2MORGAN STANLEY949,971$67.8M9.1%ADD +29.8%
3CHARLES SCHWAB INVESTMENT MANAGEMENT INC758,304$54.1M7.2%NEW
4BANK OF AMERICA CORP /DE/512,412$36.6M4.9%ADD +36.3%
5NORGES BANK450,721$32.2M4.3%NEW
6FMR LLC221,946$15.8M2.1%DOUBLED +2856.5%
7WELLS FARGO & COMPANY/MN109,672$7.8M1.0%ADD +46.3%
8TWO SIGMA INVESTMENTS, LP30,655$2.2M0.3%TRIM -26.3%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
MORGAN STANLEYADD731,901949,971+29.8%$67.8M2025-Q4
BANK OF AMERICA CORP /DE/ADD376,059512,412+36.3%$36.6M2025-Q4
NORGES BANKNEW450,721$32.2M2025-Q4
FMR LLCDOUBLED7,507221,946+2856.5%$15.8M2025-Q4
WELLS FARGO & COMPANY/MNADD74,974109,672+46.3%$7.8M2025-Q4
UBS Group AGADD255,137346,782+35.9%$26.4M2025-Q3
TWO SIGMA INVESTMENTS, LPTRIM45,68433,655-26.3%$2.6M2025-Q3
NORGES BANKEXIT545,6090-100.0%$0.002025-Q3
NORGES BANKNEW545,609$31.1M2025-Q2
TWO SIGMA INVESTMENTS, LPTRIM182,62345,684-75.0%$2.6M2025-Q2
MORGAN STANLEYADD615,652793,959+29.0%$39.5M2025-Q1
CITADEL ADVISORS LLCDOUBLED150,385708,233+370.9%$35.2M2025-Q1
UBS Group AGADD188,371314,176+66.8%$15.6M2025-Q1
TWO SIGMA INVESTMENTS, LPDOUBLED81,065182,623+125.3%$9.1M2025-Q1
FMR LLCNEAR_EXIT691,4415,443-99.2%$270.6K2025-Q1
RENAISSANCE TECHNOLOGIES LLCEXIT3,4000-100.0%$0.002025-Q1
NORGES BANKEXIT807,2890-100.0%$0.002025-Q1
UBS Group AGDOUBLED37,481188,371+402.6%$13.2M2024-Q4
WELLS FARGO & COMPANY/MNADD62,01280,243+29.4%$5.6M2024-Q4
RENAISSANCE TECHNOLOGIES LLCNEW3,400$237.5K2024-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW637,311$44.2M2024-Q3
9 unique insiders with 2 transactions. Net insider value: -$1.5M ($0.00 bought, $1.5M sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 5, 2026Berger Howard GPresident, CEOM25,992$18.64$484.5K
May 5, 2026Berger Howard GPresident, CEOM25,992$0.00$0.00
Mar 19, 2026Sorensen Alma GregoryChief Strategy OfficerSELL9,554$61.84$590.8K
Mar 19, 2026Sorensen Alma GregoryChief Strategy OfficerG7,000$0.00$0.00
Mar 18, 2026Sorensen Alma GregoryChief Strategy OfficerSELL14,200$62.12$882.1K
Mar 16, 2026Sorensen Alma GregoryChief Strategy OfficerF5,919$61.72$365.3K
Mar 10, 2026Sorensen Alma GregoryChief Strategy OfficerM3,742$0.00$0.00
Mar 10, 2026Sorensen Alma GregoryChief Strategy OfficerM3,742$0.00$0.00
Mar 3, 2026Forthuber Stephen MPres & COO-Eastern OperationsA22,045$0.00$0.00
Mar 3, 2026Patel MitalEVP of Fin Planning, CAOA20,667$0.00$0.00
Mar 3, 2026STOLPER MARKEVP, Chief Financial OfficerA18,228$0.00$0.00
Mar 3, 2026Berger Howard GPresident, CEOA124,001$0.00$0.00
Mar 3, 2026Sorensen Alma GregoryEVP, Chief Science OfficerA16,533$0.00$0.00
Mar 3, 2026Katz David JeffreyEVP and Chief Legal OfficerA19,289$0.00$0.00
Mar 3, 2026Wesdorp CornelisPres & CEO, Digital HealthA20,330$0.00$0.00
Mar 3, 2026HAMES NORMAN RPres and COO-West OperationsA22,045$0.00$0.00
Mar 3, 2026Murdock Michael NEVP, Mergers and AcquisitionsA6,613$0.00$0.00
Current analyst consensus: Strong Buy (93% buy). Based on 14 analysts: 5 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$90.38 mean target +66.7% upside Strong Buy (1.25)
$70.00 Low $100.00 High
MetricValue
Current Price$54.21
Target Low$70.00
Target Mean$90.38
Target Median$93.50
Target High$100.00
# Analysts8
RecommendationStrong Buy (1.25)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$0.21 $0.17 $0.28 -31.0% -4.2% 2↑ 2↓ $0.6B 21.7% 5
Next Q
2026-09-30
$0.27 $0.23 $0.31 35.0% +8.7% 3↑ 0↓ $0.6B 21.5% 5
Current FY
2026-12-31
$0.56 $0.45 $0.73 42.3% -11.4% 2↑ 2↓ $2.5B 21.8% 6
Next FY
2027-12-31
$1.05 $0.89 $1.22 88.5% +1.9% 2↑ 1↓ $2.7B 10.3% 5

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$0.214
7d ago$0.330-0.116
30d ago$0.223-0.009
60d ago$0.232-0.018
90d ago$0.230-0.016
3 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 20, 2026 Barclays MAINTAIN Overweight Overweight
Apr 21, 2026 Barclays MAINTAIN Overweight Overweight
Jan 9, 2026 Keybanc INITIATE Overweight
Dec 1, 2025 B. Riley Securities MAINTAIN Buy Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
May 1, 20265810093%
Apr 1, 20265810093%
Mar 1, 20265810093%
Feb 1, 20265810093%
Jan 1, 20265710092%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

50°
Neutral
Bearish Neutral Bullish
2 mentions 0 bullish 0 bearish 2 time periods

Reddit Sentiment History

DateMentionsSentimentBullishBearishThreads
May 19, 2026150° Neutral001
May 19, 2026150° Neutral001

Recent Reddit Threads

r/stocks Neutral 1d 21h ago
RDNT the AI stick saves lives
▲ 1 💬 0 ⚡ 0.5
May 11, 2026
earnings_calendar
RDNT Q1 2026 Earnings Scheduled — 2026-05-11
May 10, 2026
earnings
RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow
<p align="justify">LOS ANGELES, May 10, 2026 (GLOBE NEWSWIRE) -- <strong>RadNet, Inc. (NASDAQ: RDNT),</strong> a national leader in providing high-q
May 8, 2026
short_volume
Short Volume: RDNT — 60.7% short (0.5M / 0.8M)
Short: 512,801 | Exempt: 0 | TRF Vol: 845,308 | Short Ratio: 60.7% | Off-exchange volume (dark pool + OTC)
Apr 30, 2026
other
RadNet and Trinity Health’s Saint Alphonsus Health System Launch a Multi-Site Joint Venture in Boise, Idaho, to Include a Broad Technology Deployment of DeepHealth Solutions
RadNet forms joint venture with Saint Alphonsus Health System in Idaho, expanding its footprint and deploying DeepHealth OS to transform radiology wor
Apr 28, 2026
earnings
RadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference Call
<p align="start">LOS ANGELES, April 28, 2026 (GLOBE NEWSWIRE) -- <strong>RadNet, Inc. (NASDAQ: RDNT)</strong>, a national leader in providing high-q
Apr 28, 2026
short_interest
FTD: RDNT — 28,156 shares ($1.6M) failed to deliver
Settlement: 20260428, Price: $57.75, FTD Value: $1,626,009, RadNet, Inc. Common Stock
Apr 16, 2026
short_volume
Short Volume: RDNT — 74.6% short (0.9M / 1.2M)
Short: 889,490 | Exempt: 0 | TRF Vol: 1,191,822 | Short Ratio: 74.6% | Off-exchange volume (dark pool + OTC)
Mar 26, 2026
short_interest
FTD: RDNT — 15,992 shares ($1.0M) failed to deliver
Settlement: 20260326, Price: $60.66, FTD Value: $970,074.72, RadNet, Inc. Common Stock
Mar 20, 2026
short_interest
FTD: RDNT — 14,245 shares ($0.9M) failed to deliver
Settlement: 20260320, Price: $62.64, FTD Value: $892,306.8, RadNet, Inc. Common Stock
Mar 17, 2026
other
RadNet, Inc. to Present Today at the KeyBanc Capital Markets Healthcare Forum
<p>LOS ANGELES, March 17, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: <a href="https://www.globenewswire.com/Tracker?data=E-4Ww9Mk4m2f2lan-tw0EBM
Mar 11, 2026
earnings
RadNet, Inc. to Present at the 28th Annual Barclays Global Healthcare Conference on Thursday, March 12th
<p>LOS ANGELES, March 11, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: <a href="https://www.globenewswire.com/Tracker?data=4GdKo-qTyXLIDlEokCVG3uY
Mar 4, 2026
m_and_a
RadNet, Inc. Reminds Investors of the Dedicated Conference Call and Presentation About the Recently Completed Acquisition of Gleamer SAS
<p align="start">LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- <strong>RadNet, Inc. (NASDAQ: RDNT)</strong>, a national leader in providing high-q
Mar 2, 2026
earnings
RadNet, Inc. to Present at the Raymond James 47th Annual Institutional Investors Conference on Tuesday, March 3rd, 2026
<p align="start">LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effe
Mar 2, 2026
earnings
RadNet Reports Fourth Quarter 2025 Results, Including Record Revenue and Adjusted EBITDA⁽¹⁾ and Releases 2026 Financial Guidance
<p align="justify">LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- <strong>RadNet, Inc. (NASDAQ: RDNT),</strong> a national leader in providing high
Mar 2, 2026
m_and_a
RadNet Acquires Gleamer, Making RadNet’s DeepHealth the Largest Provider of Radiology Clinical AI Solutions Worldwide
Gleamer, one of Europe’s most recognized names in radiology AI, has been acquired by RadNet's DeepHealth